Protein expression and production at PepTalk 2027

Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website

63 organizations at PepTalk 2027 present work in protein expression and production: 29 suppliers and service providers, 20 academic, government and non-profit bodies and 14 drug developers. Between them they bring 108 presentations to the program. Most represented: AstraZeneca (10 on the program), Merck & Co. (8 on the program), Sanofi (5 on the program). As of Oct 17, 2026.

All 166 organizations at PepTalk 2027 →

Showing 1–7 of 63 organizations

Organization	PepTalk 2027 Attendance
AstraZeneca Cambridge, UK
astrazeneca.com Large pharma Global pharmaceutical company developing antibodies, multispecifics and antibody-drug conjugates across oncology, respiratory, immunology and rare diseases.	Chair Mon Jan 18 8:50am–9:00am Chairperson's Remarks SYMPOSIUM: Predictive Protein Production Talk Mon Jan 18 9:30am–10:00am In silico Developability Assessment of Single- and Dual-Chain Antibodies SYMPOSIUM: Display of Biologics Talk Mon Jan 18 11:45am–12:15pm Predictive Assembly and Purification Schema for Multispecific Biologics Using Integrated AI/ML and Experimental QC Workflows SYMPOSIUM: Predictive Protein Production Talk Tue Jan 19 11:20am–11:50am Modular Generation of Multispecific Antibodies Using Protein Trans-Splicing Multispecifics Engineering & Design Panel Tue Jan 19 11:50am–12:20pm Selecting the Optimal Multispecific Format: Engineering Strategies from Discovery to Development Multispecifics Engineering & Design · with Rondo Therapeutics, Xencor, Eli Lilly +2 more Chair Tue Jan 19 1:25pm–1:30pm Chairperson's Remarks Recombinant Protein Production - Part 1 Talk Wed Jan 20 11:10am–11:40am Lipidic Platforms for Delivery of Complex Membrane Proteins in Lead Generation Recombinant Protein Production - Part 1 Talk Wed Jan 20 2:30pm–3:00pm End-to-End Automation of Intact Mass Spectrometry QC for Integrated Purification and Quality Workflows in High-Throughput Biologics Production Tools for Purification and Quality Talk Thu Jan 21 9:10am–9:40am Fit-for-Purpose Antibody Purification: A Strategic Guide to Scale, Selection, and Automation Readiness Tools for Purification and Quality Talk Thu Jan 21 11:50am–12:20pm Improving Dual Targeting Selectivity in T Cell Engagers via Synapse-Gated and Affinity-Tuned Trispecific Antibody Design Emerging T Cell Engagers Talk Thu Jan 21 1:40pm–2:00pm Scaling the Start: High-Throughput Generation of Transfection-Ready DNA and Scalable Workflows for Rapid Antibody Production Recombinant Protein Production - Part 2 / Tools for Purification and Quality Talk Thu Jan 21 2:40pm–3:10pm Rational Antibody Engineering for Multiparameter Developability Enhancement Biophysical Methods and Models Panel Thu Jan 21 3:00pm–3:40pm Building Effective Cross-Functional Protein Production Teams Recombinant Protein Production - Part 2 / Tools for Purification and Quality · with Thomson Instrument Company, UCLA, BioMarin +1 more
Merck & Co. Rahway, NJ
merck.com Large pharma Global pharmaceutical company, called MSD outside the US and Canada, with biologics, vaccines and macrocyclic peptide research.	Talk Mon Jan 18 10:00am–10:30am When Execution is No Longer the Bottleneck: Reimagining Design of Experiments for Predictive, Data-Driven Protein Production SYMPOSIUM: Predictive Protein Production Talk Tue Jan 19 9:10am–9:40am Implementing Agentic AI and Autonomous Systems in Analytical Development Analytical Intelligence Talk Tue Jan 19 9:40am–10:10am Discovery of an NRAS Isoform and Activation-State-Selective Macrocyclic Peptide Automation in Protein Discovery / Peptide Discovery & Engineering Chair Wed Jan 20 8:30am–8:35am Chairperson's Remarks Analytical Intelligence Talk Wed Jan 20 11:10am–11:40am Modeling Stability to Support Biotherapeutics Development Analytical Intelligence Chair Wed Jan 20 2:25pm–2:30pm Chairperson's Remarks Tools for Purification and Quality Talk Wed Jan 20 3:00pm–3:30pm Investigation of Low Molecular Weight (LMW) Formation of a Multispecific Antibody by Protease Inhibitor Study Biophysical Methods and Models Talk Wed Jan 20 3:30pm–4:00pm Rapid Benchtop ¹H-NMR for Real-Time Monitoring of Purification Performance and Product Quality Tools for Purification and Quality Talk Thu Jan 21 11:50am–12:20pm Scaling Formulation Development with 384-Well ELISA for Stability, Potency, and Process Monitoring Tools for Purification and Quality Talk Thu Jan 21 2:55pm–3:20pm Enabling Oral and Parenteral GLP-1 Delivery through Biophysical and Molecular Characterizations Peptide Therapeutics: Emerging Modalities & Development
Sanofi Paris, France
sanofi.com Large pharma French pharmaceutical company with marketed medicines and vaccines, and biologics research that includes nanobody, multispecific and AI-based protein design.	Talk Mon Jan 18 1:35pm–2:05pm Two Cell Lines, One Goal: Enabling Reliable Cell-Based Assay Critical Reagent Production SYMPOSIUM: (Re) Discovering Protein Expression Platforms Talk Tue Jan 19 1:30pm–2:00pm AI-Driven Design of Mono- and Multispecific VHH Therapeutics Multispecifics Engineering & Design Talk Wed Jan 20 8:35am–9:05am Membrane Protein Expression and Production in Pharma R&D Pipelines Recombinant Protein Production - Part 1 Talk Wed Jan 20 3:30pm–4:00pm Strategic Non-Optimal Codon Usage Reduces Bispecific Protein Mispairing Recombinant Protein Production - Part 2 Chair Thu Jan 21 1:35pm–1:40pm Chairperson's Remarks Biophysical Methods and Models Talk Thu Jan 21 1:40pm–2:10pm High-Throughput Cryo Electron Microscopy and Machine Learning for Biologics Engineering: From Pipeline to Decisions Biophysical Methods and Models
Regeneron Tarrytown, NY
regeneron.com Large pharma US biotechnology company with marketed antibody medicines, built on its VelocImmune humanized-mouse platform and in-house bispecific antibody engineering.	Talk Tue Jan 19 8:40am–9:10am AI-Powered Predictive Spectral Libraries for High-Confidence Sequence Variant Analysis in Therapeutic Antibodies Analytical Intelligence Talk Tue Jan 19 9:10am–9:40am Protein Expression and G Protein-Based Functional Characterization of Orphan GPCRs Recombinant Protein Production - Part 1 Panel Tue Jan 19 11:50am–12:20pm Selecting the Optimal Multispecific Format: Engineering Strategies from Discovery to Development Multispecifics Engineering & Design · with Rondo Therapeutics, AstraZeneca, Xencor +2 more Talk Thu Jan 21 3:10pm–3:40pm A Streamlined Workflow Enabling Efficient Preclinical Development of Novel Protein Therapeutics through Risk Assessment and Enhanced Communication Bridging Research and CMC Biophysical Methods and Models
Frederick National Laboratory for Cancer Research Frederick, MD
frederick.cancer.gov Gov/NGO Federally funded biomedical research laboratory sponsored by the National Cancer Institute and operated by Leidos Biomedical Research.	Chair Mon Jan 18 8:50am–9:00am Chairperson's Opening Remarks SYMPOSIUM: (Re) Discovering Protein Expression Platforms Talk Mon Jan 18 9:00am–9:30am From Construct to Culture: Plotting a Path in Protein Production SYMPOSIUM: (Re) Discovering Protein Expression Platforms Talk Mon Jan 18 10:00am–10:30am Comparison of Insect Cell Expression Technologies SYMPOSIUM: (Re) Discovering Protein Expression Platforms Talk Tue Jan 19 11:20am–11:50am Yield and Concentration Improvements in RAF1 Ras-Binding Domain and Cysteine-Rich Domain Recombinant Protein Production - Part 1
Cytiva Marlborough, MA	◆Premier Sponsor
cytivalifesciences.com Instruments & analyticsPremier Sponsor Danaher company supplying chromatography systems and resins, Biacore binding analysis, filtration and cell culture products for biologics research and manufacturing.	Booth Exhibiting at Booth 507 Talk Tue Jan 19 10:10am–10:40am Talk Title to be Announced Multispecifics Engineering & Design Talk Tue Jan 19 12:25pm–12:55pm Talk Title to be Announced Automation in Protein Discovery Talk Wed Jan 20 4:00pm–4:30pm Talk Title to be Announced Tools for Purification and Quality
Pfizer New York, NY
pfizer.com Large pharma Global pharmaceutical company making medicines and vaccines, with in-house biologics discovery, protein engineering and protein production groups.	Talk Mon Jan 18 11:15am–11:45am Miniaturized Site-Specific Platform for Rapid Manufacturability Assessment of Biologic Candidates SYMPOSIUM: Predictive Protein Production Talk Wed Jan 20 8:35am–9:05am Engineering a p40/TL1A Bispecific Antibody for IBD: How Format Optimization Enabled Clinical Candidate Selection Multispecifics Engineering & Design Talk Wed Jan 20 11:40am–12:10pm Developing GPCR Production Workflows to Support DNA-Encoded Library Screening Recombinant Protein Production - Part 1